An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study).
Coombes RC, Tat T, Miller ML, Reise JA, Mansi JL, Hadjiminas DJ, Shousha S, Elsheikh SE, Lam EW, Horimoto Y, El-Bahrawy M, Aboagye EO, Contractor KB, Shaw JA, Walker RA, Marconell MH, Palmieri C, Stebbing J.
Coombes RC, et al. Among authors: horimoto y.
Ann Oncol. 2013 Apr;24(4):924-30. doi: 10.1093/annonc/mds594. Epub 2012 Dec 11.
Ann Oncol. 2013.
PMID: 23233650
Free article.
Clinical Trial.